How Should we Use Unproven Treatments during an Epidemic?

Written by: Published by:
Copyright holder:
Lecture date: Sun, 21st Feb, 2016
Posted on:
Estimated 33 sec read

In 2013, the world began to witness an unprecedented Ebola epidemic in West Africa that is now smoldering. Ebola virus disease has a fatality rate of up to 90%, and there are no proven vaccines or targeted treatments for the disease to date. However, several interventions were in the earliest phases of testing at the beginning of this outbreak. Heated controversy quickly arose as to whether and how these unproven interventions should be used—among researchers, humanitarian health professionals, and the affected communities, but also among bioethicists.

Dr Annette Rid discusses the key points of ethical controversy and draws some important lessons for how we should use unproven vaccines and treatments during future epidemics.




Thinking on Sunday

Share this

Dr Annette Rid ( is Senior Lecturer in Bioethics and Society at the Department of Social Science, Health & Medicine at King’s College London. Trained in medicine, philosophy and bioethics in Germany, Switzerland and the US, Annette’s research interests span research ethics, clinical ethics and justice in health and health care….